Cite
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis.
MLA
Garming Legert, Karin, et al. “Oral Mucositis after Tacrolimus/Sirolimus or Cyclosporine/Methotrexate as Graft‐versus‐host Disease Prophylaxis.” Oral Diseases, vol. 27, no. 5, July 2021, pp. 1217–25. EBSCOhost, https://doi.org/10.1111/odi.13663.
APA
Garming Legert, K., Ringdén, O., Remberger, M., Törlén, J., Mattsson, J., & Dahllöf, G. (2021). Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis. Oral Diseases, 27(5), 1217–1225. https://doi.org/10.1111/odi.13663
Chicago
Garming Legert, Karin, Olle Ringdén, Mats Remberger, Johan Törlén, Jonas Mattsson, and Göran Dahllöf. 2021. “Oral Mucositis after Tacrolimus/Sirolimus or Cyclosporine/Methotrexate as Graft‐versus‐host Disease Prophylaxis.” Oral Diseases 27 (5): 1217–25. doi:10.1111/odi.13663.